Celltrion USA Amends Rights Offering: Total Amount Reduced, Second Payment Date Set

Celltrion USA amends rights offering decision: total proceeds reduced to KRW 748.58B (USD 509.1M), second payment date set to May 13, 2026
First tranche: USD 445.8M (Dec 18, 2025); Second tranche: USD 70.3M (May 13, 2026)
Purpose: Acquisition of US API facility and operating funds (operating USD 7M, securities acquisition USD 509.1M)
Shareholder allocation, par value USD 0.0001, issuance of 100 new shares plus capital contribution without stock issuance
Exempt from securities registration as overseas unlisted company

05-11-2026 04:41 PM
[Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)
Company: Celltrion (068270)
Submission: Celltrion, Inc.
Under KRX KOSPI Market Division